BB Biotech
Stock
Stock
ISIN: CH0038389992
Ticker: BION
CH0038389992
BION
Price
Price
CHART BY
Historical dividends and forecast
BB Biotech has so far distributed $2.209 in 2024. The next dividend will be paid on 27.03.2025
$2.788
CHART BY
Frequently asked questions
What is BB Biotech's market capitalization?
The market capitalization of BB Biotech is $2.17B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is BB Biotech's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for BB Biotech is 15.49. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for BB Biotech?
BB Biotech's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $2.56. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for BB Biotech's stock?
Currently, 2 analysts cover BB Biotech's stock, with a consensus target price of $59.29. Analyst ratings provide insights into the stock's expected performance.
What is BB Biotech's revenue over the trailing twelve months?
Over the trailing twelve months, BB Biotech reported a revenue of $59.55M.
What is the EBITDA for BB Biotech?
BB Biotech's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $140.56M. EBITDA measures the company's overall financial performance.
What is the free cash flow of BB Biotech?
BB Biotech has a free cash flow of $157.23M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
What is the free float of BB Biotech's shares?
The free float of BB Biotech is 53.31M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $2.17B
- EPS (TTM)
- $2.56
- Free Float
- 53.31M
- P/E ratio (TTM)
- 15.49
- Revenue (TTM)
- $59.55M
- EBITDA (TTM)
- $140.56M
- Free Cashflow (TTM)
- $157.23M
Pricing
- 1D span
- $38.59$39.70
- 52W span
- $38.39$56.61
Analyst Ratings
The price target is $59.29 and the stock is covered by 2 analysts.
Buy
2
Hold
0
Sell
0
Information
BB Biotech AG provides investment services for biotechnology sector. It invests in portfolio of companies that are engaged in developing and marketing of innovative biotech drugs. It offers investors a exposure to a focused portfolio of predominantly-US small-to-mid-cap biotech companies developing therapeutic products, towards cell, gene and particularly RNA-based technologies. The company was founded on November 9, 1993 and is headquartered in Schaffhausen, Switzerland.
- Industries
- Financial Conglomerates
- Sector
- Financials
Identifier
- ISIN
- CH0038389992
- Primary Ticker
- BION